NONFLUENT VARIANT PRIMARY PROGRESSIVE APHASIA (NFVPPA)
Clinical trials for NONFLUENT VARIANT PRIMARY PROGRESSIVE APHASIA (NFVPPA) explained in plain language.
Never miss a new study
Get alerted when new NONFLUENT VARIANT PRIMARY PROGRESSIVE APHASIA (NFVPPA) trials appear
Sign up with your email to follow new studies for NONFLUENT VARIANT PRIMARY PROGRESSIVE APHASIA (NFVPPA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New virtual therapy aims to give voice back to those with progressive aphasia
Symptom relief Recruiting nowThis study tests a personalized, virtual speech therapy program for 30 adults with primary progressive aphasia (a type of dementia that affects language) and their communication partners. The program combines exercises, strategies, and partner training to improve communication an…
Matched conditions: NONFLUENT VARIANT PRIMARY PROGRESSIVE APHASIA (NFVPPA)
Phase: NA • Sponsor: Maya Henry • Aim: Symptom relief
Last updated May 17, 2026 13:30 UTC
-
Could a pill help restore speech in people losing their words?
Symptom relief Recruiting nowThis early study tests a drug called neflamapimod in 20 people with a rare form of primary progressive aphasia that affects speech and grammar. The goal is to see if the drug is safe and if it can improve language symptoms. Participants take the drug for a set period, and researc…
Matched conditions: NONFLUENT VARIANT PRIMARY PROGRESSIVE APHASIA (NFVPPA)
Phase: PHASE2 • Sponsor: EIP Pharma Inc • Aim: Symptom relief
Last updated May 17, 2026 13:25 UTC